Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1651 1657
This examiner grants 39% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18125616 | IMPROVED PROCESS FOR THE SEPARATION AND ANALYSIS OF PANCREATIC ENZYMES | Final Rejection | Kashiv BioSciences, LLC |
| 18023130 | METHOD FOR REMOVING ANTIFOAMING AGENTS FROM A FERMENTATION BROTH | Non-Final OA | BASF SE |
| 18549669 | GOS PRE-CONDITIONING LACTOBACILLUS STRAINS AND GOS IN FINAL FORMULATION | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18709761 | ASPERGILLUS ORYZAE STRAIN PRODUCING MYCELIUM INCLUDING ALL KINDS OF ESSENTIAL AMINO ACIDS | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 17437227 | MICROORGANISM BELONGING TO GENUS STAPHYLOCOCCUS PRODUCING ALLULOSE AND METHOD FOR PREPARING ALLULOSE USING THE SAME | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18279388 | PREPARATIONS COMPRISING PROBIOTIC STRAINS AND L-TRYPTOPHAN | Non-Final OA | EVONIK OPERATIONS GMBH |
| 18794131 | PROBIOTICS COMPOSITIONS AND METHOD OF USING THE SAME TO ENHANCE GROWTH AND SOCIAL FUNCTION IN CHILDREN | Non-Final OA | The General Hospital Corporation |
| 18800688 | Compositions and Methods for Enhanced Aquatic Farming and Aquarium Fish Husbandry | Non-Final OA | Locus Solutions IPCo, LLC |
| 17596422 | ANTIBODY PURIFICATION METHODS AND COMPOSITIONS THEREOF | Final Rejection | Takeda Pharmaceutical Company LImited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy